Walleye Trading’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-960
Closed -$98K 5755
2021
Q2
$98K Buy
960
+664
+224% +$66.7K ﹤0.01% 4388
2021
Q1
$29K Buy
+296
New +$26.9K ﹤0.01% 4470
2020
Q3
Sell
-2,044
Closed -$150K 4650
2020
Q2
$150K Sell
2,044
-183
-8% -$14.4K ﹤0.01% 3274
2020
Q1
$129K Buy
+2,227
New +$155K ﹤0.01% 2946
2018
Q4
Sell
-280
Closed -$34K 5350
2018
Q3
$34K Buy
+280
New +$34.7K ﹤0.01% 4703
2017
Q3
Sell
-3,680
Closed -$236 4622
2017
Q2
$236 Buy
+3,680
New +$227K ﹤0.01% 2991
2016
Q3
Sell
-400
Closed -$22K 5443
2016
Q2
$22K Buy
+400
New +$24.1K ﹤0.01% 4503
2016
Q1
Sell
-400
Closed -$26K 5863
2015
Q4
$26K Sell
400
-200
-33% -$13K ﹤0.01% 4284
2015
Q3
$40K Buy
600
+400
+200% +$28.3K ﹤0.01% 3663
2015
Q2
$14K Buy
+200
New +$12.7K ﹤0.01% 4175

Other funds holding USNA

Walleye Trading's USNA Position: Q3 2021 in Review

Walleye Trading sold out of Usana Health Sciences (USNA) in Q3 2021, closing a stake of 960 shares — an estimated $98K sold.

Walleye Trading first reported a position in USNA in Q2 2015 and held it in 10 quarters. The position peaked at $150K in Q2 2020. 180 funds tracked by Wall St. Rank hold USNA as of Q3 2021.

  • Walleye Trading reported no remaining Usana Health Sciences position as of Q3 2021 after selling out during the quarter.
  • Walleye Trading sold 960 Usana Health Sciences shares in Q3 2021, an estimated $98K.
  • Walleye Trading first reported a position in Usana Health Sciences in Q2 2015 and held it in 10 quarters.
  • Walleye Trading's Usana Health Sciences position peaked at $150K in Q2 2020.
  • 180 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2021.

Based on Walleye Trading's 13F filing for Q3 2021, filed 15 Nov 2021.